Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Century Therapeutics, Inc.

NASDAQ: IPSC · Life Sciences · 3 alerts · CIK 1850119

Share price
$1.64Close, Nov 16
Market cap
$298M
Shares outstanding
181.6MLatest SEC cover page
Sector
Life Sciences
Industry
Biological Products, (No Diagnostic Substances)SIC 2836

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Century Therapeutics, Inc. filings on SEC EDGAR ↗

8:19 AM ET 8-K
Clinical Trial Data

Century Therapeutics Clinical Trial Data

Century Therapeutics presented updated nonclinical data for CNTY-813, its iPSC-derived islet replacement therapy for type 1 diabetes, at the EASD 2026 meeting. The data demonstrated sustained glycemic control in diabetic mouse models for over eleven months and confirmed manufacturing consistency across five clinical-scale batches. The company remains on track to submit an IND for CNTY-813 in Q4 2026, with initial clinical data expected in the second half of 2027.

Counterparty
European Association for the Study of Diabetes (EASD)

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.